ロード中...
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
Olodaterol (BI 1744 CL) is a novel, once-daily long-acting β(2)-agonist (LABA) designed with the aim of improving β(2)-adrenoreceptor selectivity and intrinsic activity. Phase III pivotal trials have documented that olodaterol Respimat Soft Mist inhaler 5 μg induces fast onset of bronchodilation, co...
保存先:
| 出版年: | Ther Clin Risk Manag |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4675639/ https://ncbi.nlm.nih.gov/pubmed/26676161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S73581 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|